Inj, decitabine (sun pharma)
This code is not in the latest file (4Q26). It was last listed in 1Q26.
Payment limit per 1 MG, by effective quarter, 1Q23 to 1Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.This code is not in the latest file (4Q26). It was last listed in 1Q26.
Payment limit per 1 MG, by effective quarter, 1Q23 to 1Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.No NDCs mapped to this code in the 4Q26 crosswalk.
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 1Q26 | $0.777 | $0.00 | 1 MG | Inj, decitabine (sun pharma) | v1, posted September 15, 2026 |
| 4Q25 | $0.777 | $0.00 | 1 MG | Inj, decitabine (sun pharma) | v1, posted September 8, 2026 |
| 3Q25 | $0.777 | $0.00 | 1 MG | Inj, decitabine (sun pharma) | v1, posted March 10, 2026 |
| 2Q25 | $0.777 | – | 1 MG | Inj, decitabine (sun pharma) | v1, posted March 10, 2026 |
| 1Q24 | $0.777 | −$1.343 | 1 MG | Inj, decitabine (sun pharma) | v1, posted December 19, 2024 |
| 4Q23 | $2.12 | −$0.12 | 1 MG | Inj, decitabine (sun pharma) | v1, posted October 10, 2024 |
| 3Q23 | $2.24 | +$0.359 | 1 MG | Inj, decitabine (sun pharma) | v1, posted June 5, 2024 |
| 2Q23 | $1.881 | +$0.305 | 1 MG | Inj, decitabine (sun pharma) | v1, posted February 23, 2024 |
| 1Q23 | $1.576 | – | 1 MG | Inj, decitabine (sun pharma) | v1, posted December 6, 2023 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.